Dacogen

Dacogen Overdosage

Manufacturer:

Janssen

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
There is no direct experience of human overdose and no specific antidote. However, early clinical study data in published literature at doses greater than 20 times higher than the current therapeutic doses, reported increased myelosuppression including prolonged neutropenia and thrombocytopenia. Toxicity is likely to manifest as exacerbations of adverse reactions, primarily myelosuppression (see Adverse Reactions). Treatment for overdose should be supportive.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in